Trusted By
120,000+ People
| Sr.No | Publications | Click Link Here |
|---|---|---|
| 1 | Chapter "Perioperative management using insulin therapy" Vipul chavda. | Read More |
| 2 | Goklani R, Panchal D, Saboo D, Chavda V, et al, Why not SGLT-2i? Indian Journal Of Endocrinology and Metabolism | Read More |
| 3 | Shoukath M Ali; Paul Chen; Saifuddin Sheikh; Ateeq Ahmad; Moghis Ahmad; Mahesh Paithankar; Brijesh Desai; Piyush Patel; Mujtaba Khan; Alok Chaturvedi; Ronak Patel; Dharmendra T Panchal; Kuntal Shah; Vipul Chavda; Banshi D Saboo; Alpesh Patel; Imran Ahmad, Thymoquinone Co-Administered with Metformin Decreases Fasting, Post Prandial Glucose, and HbA1c in Type 2 Diabetic Patients. | Read More |
| 4 | Parekh M, Saboo B, Panchal D, Goklani R, Chavda V, Hasnani D. To estimate the prevalence of obesity and abdominal obesity in adult patients. In22nd European Congress of Endocrinology 2020 Aug 21 (Vol. 70). BioScientifica. | Read More |
| 5 | Shah S, Saboo B, Shah S, Hasnani D, Chavda V, Kesavadev J, Shah Hb, Patel Kj. 2230-PUB: A Portrait of HbA1c Levels amongst Adults Diagnosed with Diabetes Mellitus in Suburban Ahmedabad. | Read More |
| 6 | Chavda V, Hasnani D, Saboo Bd, Shah S, Saiyed M, Hasnani S. 2138-PUB: Determining Early Stage CVD in Patients of T2DM Using Flow-Mediated Dilatation Score. | Read More |
| 7 | Chavda Vipul, Saboo Banshi, Hasnani Shriji, Hasnani Dhruvi, Saiyed Mahira, Chandarana Hardik. Efficacy of Cilnidipin vs. Amlodipin on microalbuminuria in hypertensive patients- clinical experience Oct 2018 Journal of hypertension Vol:36 | Read More |
| 8 | Dipak b. chudasama, Banshi d. saboo, Dharmendra panchal, Fenypatel, Mahirasaiyed, Dhruvihasnani, Vipul chavda, Hardik chandarana and Rutul goklani. The Efficacy of Teneligliptin with Metformin in Drug-Naïve Type 2 Subjects July 2018 Published in American Diabetes Association | Read More |
| 9 | MahiraKadri, DhruviHasnani, FenyPatel, BanshiSaboo,ChavdaVipul, GoklaniRutul, HasnaniShriji, PanchalDharmendra. Use of Empagliflozin as a Second Line Agent – Real Life ExperienceJune 2018 Journal of Atherosclerosis Supplements Volume 32 | Read More |
| Sr.No | Publications | Click Link Here |
|---|---|---|
| 1 | Evaluation of the Patient Perceptions towards the Cost of Diabetes Therapy During the COVID-19 Era | Read More |
| 2 | Determining Early Stage CVD in Patients of T2DM Using Flow-Mediated Dilatation Score | Read More |
| 3 | Effectiveness of a Community-Based Approach Towards the Treatment and Prevention of Diabetes Mellitus in Rural India | Read More |
| 4 | A Portrait of HbA1c Levels amongst Adults Diagnosed with Diabetes Mellitus in Suburban Ahmedabad | Read More |
| 5 | Determining Early Stage CVD in Patients of T2DM Using Flow-Mediated Dilatation Score | Read More |
| 6 | The Efficacy of Teneligliptin with Metformin in Drug-Naïve Type 2 Subjects | Read More |
| Sr.No | Publications | Click Link Here |
|---|---|---|
| 1 | SPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes.Adolfsson P, Riddell MC, Taplin CE, Davis EA, Fournier PA, Annan F, Scaramuzza AE, Hasnani D, Hofer SE. Pediatr Diabetes. 2018 Oct;19Suppl 27:205-226. doi: 10.1111/pedi.12755. | Read More |
| 2 | The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes-A SWEET collaborative study.Svensson J, Schwandt A, Pacaud D, Beltrand J, Birkebaek NH, Cardona-Hernandez R, Casteels K, Castro S, Cherubini V, Cody D, Fisch N, Hasnani D, Kordonouri O, Kosteria I, Luczay A, Pundziute-Lyckå A, Maffeis C, Piccini B, Luxmi P, Sumnik Z, de Beaufort C. Pediatr Diabetes. 2018 Dec;19 (8):1441-1450. doi: 10.1111/pedi.12751. Epub 2018 Oct 10 | Read More |
| 3 | “Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience.” | Read More |
| 4 | “Contribution of SWEET to improve paediatric diabetes care in developing countries.” | Read More |
| 5 | To Assess the Effect of 4mg Saroglitazar on Patients of Diabetes Dyslipidemia with Nonalcoholic Fatty Liver Disease for 24 Weeks at Diabetes Care Centre. Saboo, B.D., Prajapati, A., Joshi, S., Bhandari, S., Shah, A.N., Jaiswal, A. and Hasnani, D., 2015, June. In DIABETES (Vol. 64, pp. A180-A180). 1701 n Beauregard St, Alexandria, va 22311-1717 USA: Amer Diabetes assoc. | Read More |
| 6 | “Environmental modulators of type 1 diabetes mellitus” | Read More |
| Sr.No | Publications | Click Link Here |
|---|---|---|
| 1 | Chapter in Insulin Monogram 2019: “Perioperative use of Insulin”- Dhruvi Hasnani, Vipul Chavda | Read More |
| 2 | Sweetening 16 | Read More |
| 3 | Management of Diabetes during Fasting and Feasting in India.Saboo B, Joshi S, Shah SN, Tiwaskar M, Vishwanathan V, Bhandari S, Jha S, Chaudhary T, Arvind SR, Chawla R, Kalra S, Hasnani D. J Assoc Physicians India. 2019 Sep;67(9):70-77 | Read More |
| 4 | Strengthening the Family - the 'Five-I' Approach. Kalra S, Saboo B, Cho NH, Sadikot S, Hasnani D, Chandarana H, Verma M, Bhandari S, Gupta A, Aravind SR. EurEndocrinol. 2019 Apr;15(1):15-16. doi: 10.17925/EE.2019.15.1.15. Epub 2019 Apr 12. | Read More |
| 5 | Use of Ambulatory Glucose Profile for Improving Monitoring and Management of T2DM.Saboo B, Sheth SV, Joshi S, Bhandari S, Kesavadev J, Maheshwari A, Agrawal M, Hasnani D, Patel F, Panchal D, Goklani R. J Assoc Physicians India. 2018 Jul;66(7):69-71. | Read More |
| 6 | lue Index—The Diabetes Health Score Dharmendra Panchal, Sanjeev Phatak, Padmanabh Zinzuwadia, Banshi D. Saboo, Dhruvi Hasnani, Sanjay Kalra, A. K. Das, Shivangi Dwivedi Diabetes 2018 Jul; 67(Supplement 1) | Read More |
| 7 | Chapter submission “Metformin in Young” in book - Frontiers of Diabetes, 2016. | - |
| Sr.No | Publications | Click Link Here |
|---|---|---|
| 1 | Evaluation of the Patient Perceptions towards the Cost of Diabetes Therapy During the COVID-19 Era | Read More |
| 2 | Intervention of a personalized low-carbohydrate diet to reduce HbA1c level and weight in patients with Type 2 diabetes using seed-based flour as replacement for high-carbohydrate flour and foods | Read More |
| 3 | Worldwide differences in childhood type 1 diabetes: The SWEET experience | Read More |
| 4 | To estimate the prevalence of obesity and abdominal obesity in adult patients | Read More |
| 5 | An Under-Utilized Tool for Screening of ASCVD in Diabetes | Read More |
| 6 | Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience | Read More |
| 7 | Effectiveness of a Community-Based Approach Towards the Treatment and Prevention of Diabetes Mellitus in Rural India | Read More |
| 8 | Determining Early Stage CVD in Patients of T2DM Using Flow-Mediated Dilatation Score | Read More |
| 9 | Management of Diabetes during Fasting and Feasting in India | Read More |
| 10 | Clinical Importance of Screening for Sleep Disorders for Chronic Disease | Read More |
| 11 | Strengthening the Family - the 'Five-I' Approach | Read More |
| 12 | Efficacy of Cilnidipin vs. Amlodipin on microalbuminuria in hypertensive patients- clinical experience | Read More |
| 13 | ISPAD Clinical Practice Consensus Guidelines 2018 Compendium Exercise in children and adolescents with diabetes. | Read More |
| 14 | The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes – A SWEET collaborative study. | Read More |
| 15 | The Blue Index -A Comprehensive Diabetes Assessment Score CHALLENGES APLENTY | Read More |
| 16 | Use of Ambulatory Glucose Profile for Improving Monitoring and Management of T2DM | Read More |
| 17 | Use of Empagliflozin as a Second Line Agent – Real Life Experience | Read More |
| 18 | Efficacy of a Basal-Plus Regimen | Read More |
| 19 | Retrospective Analysis of Correlation between Peripheral Artery Disease and Diabetic Retinopathy in Type 2 Diabetes Patients | Read More |
| 20 | The Efficacy of Teneligliptin with Metformin in Drug-Naïve Type 2 Subjects | Read More |
| 21 | RSSDI clinical practice recommendations for management of In-hospital hyperglycaemia—2016 | Read More |
| 22 | Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience | Read More |
| 23 | Contribution of SWEET to improve paediatric diabetes care in developing countries | Read More |
| 24 | "EVALUATION OF TENELIGLIPTIN ACROSS THE INDIAN URBAN SETTING- INITIAL REAL WORLD EXPERIENCE" | Read More |
| 25 | Abstract #419: Analysing Endothelial Dysfunction in Type2 Diabetes Mellitus Patients Using Flow Mediated Dilatation Score. | Read More |
| Sr.No | Name of Trial | Year | Type of Study | PI |
|---|---|---|---|---|
| 1 | A Phase IIb, Open-label, Randomized, Comparative Study to Evaluate the Safety and Efficacy of USVCAP Formulation in Type 2 Diabetes Mellitus Subjects Uncontrolled with Metformin Hydrochloride Treatment | 2019 | Phase II | Dr. Vipul Chavda |
| 2 | A Randomized, Open label, Prospective, Three Arm, Parallel, Multicenter study to Evaluate Efficacy and Safety of Metformin with / without Concomitant Administration of Thymoquinone in Patients with Type 2 Diabetes Mellitus (Phase ii) | 2019 | Phase II | Dr. Vipul Chavda |
| 3 | 21455 – START-AM- Acarbose/Metformin Fixed Dose Combination: Treatment patterns and Outcomes in Newly Diagnosed T2DM patients in India | 2020 | Phase IV | Dr. Dhruvi Hasnani |
| 4 | “Safety and Efficacy of Nimesulide/Paracetamol Fixed-Dose Combination in Acute Pain (SAFE Study)” | 2021 | Phase IV | Dr. Vipul Chavda |
| 5 | A Randomized, Open label, Prospective, Three Arm, Parallel, Multicenter study to Evaluate Efficacy and Safety of Metformin with / without Concomitant Administration of Thymoquinone in Patients with Type 2 Diabetes Mellitus (phase iii) | 2021 | Phase III | Dr. Vipul Chavda |
| 6 | A Phase 3, multicenter, randomized, double-blind, double-dummy, parallel-group, active-controlled study to compare the efficacy and safety of a fixed dose combination of Metformin hydrochloride 1000 mg SR, Sitagliptin 100 mg and Pioglitazone 15 mg tablets versus Janumet XR CP (Combipack of Metformin hydrochloride 1000 mg SR and Sitagliptin phosphate100 mg) in patients with Type 2 Diabetes Mellitus (T2DM) | 2021 | Phase III | Dr.Dhruvi Hasnani |
| 7 | Treatment Optimization for blood Pressure with Single-Pill combinations in India | 2022 | Phase IV | Dr. Vipul Chavda (co-i) |
| 8 | Sweet Project -International Society of Pediatric & Adolescent Diabetes | Cont | Registry | Dr. Vipul Chavda |
| 9 | Hyperglycemia in pregnancy-demographic mapping and outcome study. | 2022 | Academic | Dr. Vipul Chavda |
| 10 | A clinical study: Evaluation of metabolic parameters of sexual dysfunction in patient with type-2 diabetes | 2022 | Academic | Dr. Vipul Chavda |
| 11 | ACP-India NEODIAB-COVID study – retrospective cross-sectional demographics of newly detected diabetes post-COVID-19 | 2022 | Real world study | Dr. Vipul Chavda |
| 12 | A multicentre, prospective, non-interventional single-arm study evaluating clinical parameters associated with the use of once-daily oral Semaglutide in a real-world adult population with type 2 diabetes in India (PIONEER REAL INDIA) | 2022 | Real world study | Dr.Dhruvi Hasnani |
| 13 | Assessment of drug prescription patterns of patients with Hypertension and Type 2 Diabetes Mellitus in India | 2022 | Registry | Dr. Vipul Chavda |
| 14 | Hyperglycemia in pregnancy-demographic mapping and outcome study. | 2022 | Academic | Dr. Vipul Chavda |
| 15 | A multicentre, prospective, non-interventional single-arm study evaluating clinical parameters associated with the use of once-daily oral Semaglutide in a real-world adult population with type 2 diabetes in India (PIONEER REAL INDIA) | 2022 | Phase IV | Dr. Dhruvi Hasnani |
| 16 | Efficacy & safety of Coformulation IDegAsp vs IGlargineU300 in insulin naive T2DM | 2022 | Academic | Dr. Dhruvi Hasnani |
| 17 | A Randomized, Double-blinded, Parallel, Placebo-controlled, Multicenter, bioequivalence study with clinical endpoint to assess efficacy and safety of Linaclotide 145 mcg capsule (manufactured by Arab Pharmaceutical Manufacturing PSC, Jordan for Hikma Pharmaceuticals (MAH)) to LINZESS® (linaclotide) 145 mcg capsules (Allergan USA, Inc. Madison, NJ 07940) in the treatment of chronic idiopathic constipation. | 2023 | Phase III | Dr. Vipul Chavda |
| 18 | A randomized, international, multicenter single-blind study to compare the efficacy and safety of PZN-128 powder for solution for subcutaneous injection 250 µg (Pharmasyntez-Nord JSC, Rus-sia) versus ?comparator drug in patients with chronic idiopathic (immune) thrombocytopenic purpura | 2023 | Phase III | Dr. Vipul Chavda (co-i) |
| 19 | Prevalence of Subclinical hypothyroidism in Indian patients with Type 2 diabetes mellitus - a real-world multi-centric study. | 2023 | Real world study | Dr. Vipul Chavda |
| 20 | Real world study On the Impact of vitamin D deficiency on Insulin Resistance in Type 2 Diabetes Mellitus patients in India | 2023 | Real world study | Dr. Vipul Chavda |
| 21 | Prevalence of anemia in patients visiting physician clinic in india. | 2023 | Real world study | Dr. Dhruvi Hasnani |
